Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04549493 · ClinicalTrials.gov registry record · NA

Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy

A NA study of PTSD, sponsored by University of Central Florida.

Completed
Registry status
NA
Development phase
134
Enrollment target
1
Study location

NCT04549493 is a NA study of PTSD that has completed, run by University of Central Florida. The registered enrollment target is 134 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04549493, a NA study of PTSD, has completed, sponsored by University of Central Florida.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target
1
Study location

Study Summary

The purpose of this requirement is to identify an effective exposure psychotherapy paradigm for the treatment of Post-Traumatic Stress Disorder (PTSD) in active duty service members and veterans by comparing different exposure psychotherapy modalities. The long-term goal of exposure psychotherapy is to improve the mental health of U.S. service members and veterans with military-related PTSD. Recovery from PTSD will reduce the economic burden not only for those persons experiencing PTSD, but also for the health care system and society as a whole (Galovski \& Lyons, 2004).

Conditions Studied

Interventions

  • BEHAVIORAL Exposure Therapy

Study Locations (1)

Florida

  • UCF RESTORES, University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2020-02-12
Est. Completion 2024-05-01
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT04549493

The ClinicalTrials.gov registry entry for NCT04549493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (55% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Exposure Therapy is the first listed.

NCT04549493 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04549493 about?

NCT04549493 is a clinical study titled "Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy". The purpose of this requirement is to identify an effective exposure psychotherapy paradigm for the treatment of Post-Traumatic Stress Disorder (PTSD) in active duty service members and veterans by comparing different exposure psychotherapy modalities. The long-term goal of exposure psychotherapy is...

What is the current status of trial NCT04549493?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2020-02-12. Estimated completion is 2024-05-01.

What conditions does trial NCT04549493 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT04549493?

The interventions under investigation include: Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04549493?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04549493 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.